HealthEquity Reports Second Quarter Ended July 31, 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Oil rally pressures S&P, Nasdaq; Microsoft, Salesforce buoy Dow
- Oil prices rise 2% as attacks on Saudi Arabia overshadow Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
Jefferies Reiterates Buy Rating on HealthEquity, Inc (HQY) Following Beat and Raise
September 7, 2022 8:22 AM EDTJefferies analyst Glen Santangelo reiterated a Buy rating and $80.00 price target on HealthEquity, Inc (NASDAQ: HQY) following Q2 beat and raise.
The analyst commented, "2Q beat & raise was driven by ongoing momentum in HSA acct/asset growth and higher HSA yield -owing... More
HealthEquity (HQY) Reports In-Line Q2 EPS
September 6, 2022 4:02 PM EDTHealthEquity (NASDAQ: HQY) reported Q2 EPS of $0.33, in-line with the analyst estimate of $0.33. Revenue for the quarter came in at $206.1 million versus the consensus estimate of $203.82 million.
GUIDANCE:
HealthEquity sees FY2022 EPS of $1.23-$1.32, versus the consensus of $1.28. HealthEquity sees... More



